Mild adverse events are typically monitored through surveillance systems like the Vaccine Adverse Event Reporting System (VAERS) in the United States. Healthcare providers and patients report any side effects, which are then analyzed to identify patterns and potential safety concerns. Clinical trials also play a significant role in identifying mild adverse events before a treatment is approved for general use.
